Zynga, well-known for social videogames like Farmville and Cityville, has confirmed its partnership with Chinese social-networking site Sina to release Chinese versions of its Draw Something mobile game.
The simplified and traditional Chinese-language version of Draw Something will be produced target Zynga fans in mainland China.
The mobile game will also be launched in eleven other languages, including Japanese, French, Italian, Swedish, Dutch, Spanish, Brazilian Portuguese, Norwegian, and German.
David Ko, chief mobile officer at Zynga, said, “With native pop culture references and our partnership with global superstars such as Enrique Iglesias and Jennifer Lopez, the game will be even more fun for more players.”
San Francisco-based Zynga has for sometime increasingly focusing its attention on mobile video games. Sean Uberoi Kelly, vice president of product development at Zynga, recently announced the company was trying to grow its portfolio of mobile social games for iOS as well as Android.
Mobile devices have their own advantages as their users can play games anywhere, anytime according to their convenience.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).